- Record: found
- Abstract: not found
- Article: not found
Rebound Syndrome in Patients With Multiple Sclerosis After Cessation of Fingolimod Treatment
Stacy Ellen Hatcher
1 ,
Emmanuelle Waubant
1 ,
Bardia Nourbakhsh
1 ,
Elizabeth Crabtree-Hartman
1 ,
Jennifer S. Graves
1
July 01 2016
July 01 2016
Read this article at
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
The appropriate sequencing of agents with strong immune system effects has become
increasingly important. Transitions require careful balance between safety and protection
against relapse. The cases presented herein highlight that rebound events after ceasing
fingolimod treatment may happen even with short washout periods (4 weeks) and may
perpetuate despite steroid treatment or the immediate use of fast-acting immune therapies,
such as rituximab.